EMA Says No Evidence for Link between Type 2 Diabetes Drugs and Suicidal Tendencies

The agency’s risk assessment committee has concluded that available evidence has not been found that supports a causal association between glucagon-like peptide-1 receptor agonists and self-harming thoughts and actions.